MAP3K8 and urinary bladder carcinoma: Here we showed that the PDE4D activity was repressed by the constitutive activation of TPL2/ERK in bladder cancer cells and the antitumor effect of IFN-α-induced TPL2/ERK inhibition partially depended on the PDE4D-mediated cAMP level.